Anthony Coyle
President, Research and Development at Repertoire Immune Medicines
Cambridge, Massachusetts, United States
Find your path to Anthony
53 people in our graph share verified history with Anthony — schools, employers, funds. One of them is your warm intro.
Mojca SkoberneunlockedAnthony: together at Repertoire Immune Medicines (2020–2021)
×4Anthony: together at King's College London
Anthony: together at Repertoire Immune Medicines
×4Anthony: together at Pandion Therapeutics
President, Research and Development at Repertoire Immune Medicines
Intro paths
→
In turn, Anthony can intro founders to Repertoire Immune Medicines's investors below.
Repertoire Immune Medicines's investors · 3
Experience
- Repertoire Immune MedicinesPresident, Head of Research and Developmentcurrent2020 — presentCambridge, Massachusetts, United States
- Pandion TherapeuticsChief Executive Officer and Founder2017 — 2019
- PfizerSenior Vice President and CSO: Centers for Therapeutic Innovation2010 — 2017
- MedImmuneVP, Global Head, Inflammation Biologics2007 — 2010
- MedImmuneHead, Respiratory Inflammation and Autoimmune Research Biology2004 — 2006
- Millennium PharmaceuticalsDirector, Inflammation Biology1997 — 2004
- Ciba-Geigyscientist1992 — 1996
- Glaxo Institute for Molecular BiologyResearch Scientist1993 — 1995
- National Jewish Centre for Immunology and Respiratory MedicinePost Doctorial Research Assistant1990 — 1992
- Institut PasteurPost Doctorial Assistant1989 — 1990
Skills & more
Asthma64Autoimmune Diseases22BiologicsBiochemistry34Leadership4Drug Development8Biotechnology6Immunology5
From Anthony's professional profile.
Frequently asked questions
- Who is Anthony Coyle?
- President, Research and Development at Repertoire Immune Medicines
- Where does Anthony Coyle work?
- Anthony Coyle is President, Research and Development at Repertoire Immune Medicines.
- Where did Anthony Coyle go to school?
- Anthony Coyle studied at King's College London (PhD, Pharmacology); King's College London (Bsc Honours, Pharmacology).
Same school
Also attended King's College London381
Harry StebbingsFounder & General Partner at 20VCDominic JacquessonInvestor at Index VenturesJohn HortonInvestor at DN CapitalBob ThomasPartner at OxxKatherineHealthcare Investment Lead at Hummingbird VenturesÖzge Gizem YerlikayaGeneral Counsel at Idacapital
+ 375 more
Shared employers
Also worked at Repertoire Immune Medicines7
Mojca SkoberneEntrepreneur in Residence at GV (Google Ventures)Noubar AfeyanInvestor at Flagship PioneeringElisabeth BrownStudent Analyst at Utah Innovation FundJohn DelyaniChief Business Officer at Repertoire Immune MedicinesLovisa AfzeliusExecutive Chair & Founding CEO at AllTrnaAndrea DiFabioChief Legal Officer and Corporate Secretary at Xenon Pharma
+ 1 more
Also worked at Pfizer401
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital
+ 395 more
Also worked at MedImmune28
Damian Crowtherex-AstraZeneca at PICUS CAPITALArthur SuckowInvestor at 82VSEd MathersPartner at New Enterprise Associates (NEA)Celia HartGeneral Partner at Supernova InvestKevin TyanInvestor at VenrockJennifer ButlerEntrepreneur-in-Residence at BioHealth Innovation, Inc.
+ 22 more
Also worked at Millennium Pharmaceuticals52
David SchenkeinInvestor at GV (Google Ventures)Kevin MunnellyInvestor at Third Rock VenturesJohn KeiltyVenture Partner at Third Rock VenturesKevin GillisPartner and Chief Operating Officer at Third Rock VenturesNeil ExterRetired Partner at Third Rock VenturesRobert TepperPartner and co-founder of Third Rock Ventures
+ 46 more